Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Acta Medica Okayama|June 30, 2026
Peripheral Blood T-Cell Receptor Repertoire and Host Immune Background in Breast Cancer Patients Undergoing Neoadjuvant ChemotherapyYuki Nakamura, Takayuki Iwamoto, Yukiko Kajiwara, et al.
Breast Cancer (Tokyo, Japan)|April 13, 2016
N-acetyltransferase 2 polymorphism and breast cancer risk with smoking: a case control study in Japanese womenAkio Hara, Naruto Taira, Taeko Mizoo, et al.
Acta Medica Okayama|April 21, 2018
Current Multidisciplinary Approach to Fertility Preservation for Breast Cancer PatientsYuko Takahashi, Tadahiko Shien, Ai Sakamoto, et al.
Surgical Case Reports|January 18, 2020
Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case reportYoko Suzuki, Kohei Taniguchi, Minami Hatono, et al.
Breast Cancer (Tokyo, Japan)|May 26, 2025
Immediate breast reconstruction surgery for breast cancer: current status and future directionsTadahiko Shien, Hiroko Nogi, Akiko Ogiya, et al.
BMC Cancer|December 3, 2013
Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case-control study in Japanese womenTaeko Mizoo, Naruto Taira, Keiko Nishiyama, et al.
Breast Cancer (Tokyo, Japan)|December 17, 2022
Physicians' perception about the impact of breast reconstruction on patient prognosis: a survey in JapanRena Yamakado, Makoto Ishitobi, Naoto Kondo, et al.
Breast Cancer (Tokyo, Japan)|September 16, 2016
Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancerAkiko Ogiya, Kieko Yamazaki, Rie Horii, et al.
Breast Cancer Research and Treatment|June 27, 2024
Comparison of proportions and prognostic impact of pathological complete response between evaluations of representative specimen and total specimen in primary breast cancer after neoadjuvant chemoradiotherapy: an ancillary study of JCOG0306Tadahiko Shien, Hitoshi Tsuda, Keita Sasaki, et al.
Cancer Science|July 24, 2022
Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer-associated fibroblastKosuke Ochi, Ken Suzawa, Yin Min Thu, et al.
Pageof 16